Search Results 1601-1610 of 14843 for anti-TNF drugs

1. Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis - Mayo Clinic

   The purpose of this study is to determine whether Cenicriviroc is effective and safe in the treatment of nonalcoholic steatohepatitis (NASH) in adult subjects ...

2. LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma - Mayo Clinic

   About this study. The primary purpose of this study is to assess the anti-tumor activity of LGX818/MEK162 in combination with targeted agents after ...

3. Atezolizumab (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

4. Risperidone (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

5. Abacavir, Dolutegravir, And Lamivudine (Oral Route) Proper Use - Mayo Clinic

   Be sure to take all of the medicines your doctor ordered, and to take them at the right times. You may take this medicine with or without food. Swallow the ...

6. Fezolinetant (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

7. Thyrotropin Alfa (Intramuscular Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. Descriptions. Thyrotropin alfa injection is a form of human thyroid ...

8. Overview - Department of Immunology - Mayo Clinic Research

   The Department of Immunology at Mayo Clinic is an academic department focused on understanding fundamental aspects of immunology in human health & disease.

9. Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... Refractory to prior anti-PD-1/PD-L1 agent.

10. New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery - Mayo Clinic News Network

    "Future studies may allow the use of this biomarker along with standard clinicopathological factors to inform treatment decisions in TNBC patients." "Of ...